LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
10.46 27.76 947 438 2.1589 1.4264
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
10.46 27.76 30 438 0.0684 0.0197
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
10.46 27.76 1103 438 2.5146 1.5211
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
12.17 27.76 1 489 0.0020 -0.5520
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
12.17 27.76 985 489 2.0140 1.3686
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
12.17 27.76 34 489 0.0695 0.0502
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
12.17 27.76 1056 489 2.1592 1.4088
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
13.87 27.76 1 604 0.0017 -0.5265
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
13.87 27.76 1027 604 1.6983 1.2531
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
13.87 27.76 51 604 0.0843 0.1466
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
13.87 27.76 1249 604 2.0654 1.3545
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
15.58 27.76 1 685 0.0015 -0.5125
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
15.58 27.76 1089 685 1.5885 1.2104
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
15.58 27.76 84 685 0.1225 0.2704
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
15.58 27.76 1358 685 1.9808 1.3184
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
17.28 27.76 118 838 0.1407 0.3422
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
17.28 27.76 1169 838 1.3938 1.1397
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
17.28 27.76 97 838 0.1157 0.2898
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
17.28 27.76 1437 838 1.7133 1.2314
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
18.98 27.76 162 941 0.1721 0.4149
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
18.98 27.76 1288 941 1.3685 1.1273
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
18.98 27.76 130 941 0.1381 0.3549
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
18.98 27.76 1546 941 1.6427 1.2051
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
20.68 27.76 508 1119 0.4540 0.7247
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
20.68 27.76 1427 1119 1.2752 1.0933
MN20160318_Q01
H11